… Inflammation is a shared hallmark between amyotrophic lateral sclerosis (ALS) and …
reasons of failures linked to therapeutic trials with immunomodulator drugs. Then we present the …

… Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease that lacks an effective
treatment. … Moreover, bench-to-bedside translation is complicated in the absence of well-…

… Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are common
neurodegenerative disorders that are relentlessly progressive, fatal, and without effective treatment, …

… Finally, I provide evidence that administration of 50mg/kg CBD as a novel treatment is not …
potential of eg novel treatments in diseases with narrow treatment windows such as ALS. …

… ), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS) and Huntington’s disease
(… and treatments that can reshape the gut microbiome, serving as potential therapies for NDs (…

… Amyotrophic lateral sclerosis (ALS) is a neuronal degenerative condition identified via a …
in ALS pathogenesis presents a significant challenge in its treatment. Here, we review how the …

… Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with no modifying
treatments available. The molecular mechanisms underpinning disease pathogenesis are …

… However, two editors’ letters pointed out the lack of adjustment of body mass index (BMI)
in the analyses, the exclusion of patients with T1DM, and the role of drug medication on the …

… Medication interactions and the need for additional referrals and … bench Lift chair/seat
Hoyer lift Pivot transfer device Hospital bed Grab bars Handheld shower equipment Bedside …

… only treatment [12]. In 2017, the second drug approved by the US Food and Drug Administration
(… ; however, it has not been approved by European Medicine Agency (EMA). A study on …